Back to Blog
Advanced Treatment

TORS Robotic Surgery Chennai | Dr Vidhyadharan

January 10, 2025
5 min read
By Dr. Vidhyadharan Sivakumar
TORSrobotic surgeryda Vinci robotthroat cancerminimally invasive surgeryChennai
TORS Robotic Surgery Chennai | Dr Vidhyadharan

Need expert consultation? Book an appointment with Dr. Vidhyadharan at THANC Hospital.

Book Appointment

Transoral Robotic Surgery (TORS) represents a major advancement in throat cancer treatment. Using the da Vinci Xi robotic system, surgeons can now remove tumors through the mouth with unprecedented precision, eliminating large external incisions. At THANC Hospital Chennai, Dr. Vidhyadharan Sivakumar brings extensive expertise in robotic surgery, having performed India's first TORS-assisted total laryngectomy.

What is TORS Robotic Surgery?

TORS uses the da Vinci Surgical System to access and remove throat tumors through the mouth. The surgeon operates from a console, controlling robotic arms equipped with specialized instruments and a high-definition 3D camera. This provides:

  • 10x Magnification with crystal-clear 3D vision
  • 7 Degrees of Freedom - greater range than the human wrist
  • Tremor Elimination - computer-stabilized precision movements
  • Superior Depth Perception for navigating complex anatomy

Who is a Candidate for TORS?

Suitable Conditions

  • Tonsil cancer and base of tongue tumors
  • Oropharyngeal cancer (HPV-positive cancers respond excellently)
  • Early laryngeal cancer (selected cases)
  • Stage I-III tumors accessible through the mouth

Patient Requirements

  • Adequate mouth opening for robotic arm access
  • Fitness for general anesthesia
  • Tumor location reachable through oral approach

TORS vs Traditional Surgery: Key Differences

FactorTORSTraditional Open Surgery
IncisionsNone (through mouth)External neck incisions
Hospital Stay2-4 days7-14 days
Return to Work3-4 weeks6-12 weeks
Return to Normal Diet2-3 weeks4-8 weeks
ScarringNone visibleVisible neck scar
Speech Preservation90-95% maintain good speechHigher risk of impairment
Swallowing90% near-normal functionMore significant impact
Blood LossMinimalMore
Complication RatesLowerHigher

TORS vs Radiation Therapy

For early-stage throat cancers, both TORS and radiation are effective. Here's how they compare:

FactorTORSRadiation
Treatment DurationSingle surgery6-7 weeks daily
Hospital Stay2-4 daysOutpatient
Long-term Dry MouthRareCommon (permanent)
Taste ChangesMinimal/temporaryFrequent/lasting
Dental ProblemsMinimalIncreased risk
Hypothyroidism RiskLowModerate
If Cancer ReturnsRadiation availableRe-irradiation difficult

In many early-stage cases, TORS alone may be sufficient, potentially avoiding radiation and its long-term side effects entirely.

The TORS Procedure at THANC Hospital

Pre-Operative Assessment

  1. Comprehensive CT/MRI imaging to map tumor extent
  2. Flexible laryngoscopy examination
  3. Anesthesia fitness evaluation
  4. Detailed discussion of risks and benefits

During Surgery

  • Duration: Typically 2-4 hours
  • General anesthesia throughout
  • Robot positioned at patient's head
  • Surgeon operates from console with 3D visualization
  • Tumor removed with precise margins
  • Specimen sent for pathology confirmation

Post-Operative Recovery

  • Day 0-1: ICU monitoring, pain management
  • Day 1-2: Start liquids, begin mobilization
  • Day 2-4: Soft diet advancement, discharge planning
  • Week 1-2: Gradual diet progression at home
  • Week 2-6: Speech and swallowing therapy as needed

Real-World Outcomes

Success Rates

  • Tumor Control: 85-95% for early-stage cancers
  • Voice Preservation: 90-95% maintain good speech
  • Swallowing Function: 90% return to near-normal diet
  • Quality of Life: Superior to open surgery or radiation alone

Long-Term Benefits

  • Lower risk of chronic complications
  • Better long-term swallowing function
  • Reduced need for feeding tubes
  • No visible external scars
  • Radiation remains available if needed later

Potential Complications

Common (Usually Temporary)

  • Throat pain and discomfort
  • Temporary difficulty swallowing
  • Mild taste changes
  • Tongue numbness (if tongue base involved)

Uncommon (1-2%)

  • Bleeding requiring intervention
  • Infection
  • Temporary feeding tube requirement

Rare

  • Prolonged swallowing difficulty
  • Permanent voice changes
  • Emergency tracheostomy need

Dr. Vidhyadharan's TORS Expertise

Dr. Vidhyadharan Sivakumar brings exceptional credentials in robotic surgery:

Qualifications

  • MCh (Head & Neck Surgery) - Gold Medal, First Rank
  • Fellow, Indian College of Robotic Surgeons (FICRS)
  • Fellow, European Board of Otorhinolaryngology (FEB-ORL HNS)
  • Advanced robotic surgery training in Australia on da Vinci Xi system

Achievements

  • India's First TORS-assisted Total Laryngectomy (2022)
  • Member of World's First Endo-Robotic Surgery Team (2023)
  • Trained across 8 countries including Australia, Taiwan, Singapore

THANC Hospital Facilities

  • Latest da Vinci Xi Robotic System
  • Dedicated robotic surgery OR staff
  • Comprehensive speech and swallowing therapy
  • Multidisciplinary oncology coordination

Is TORS Right for You?

If you've been diagnosed with throat, tonsil, or tongue base cancer, TORS may be an excellent option. The ideal time to explore this is during your initial consultation, before starting any treatment.

Questions to Ask

  1. Am I a candidate based on my tumor location and stage?
  2. Would TORS alone be sufficient, or will I need radiation?
  3. What are the expected functional outcomes for my specific case?
  4. How many TORS procedures has my surgeon performed?

Ready to explore if TORS is right for you? Schedule a consultation with Dr. Vidhyadharan at THANC Hospital, Chennai.

Phone: +91 44 4074 2000 Location: THANC Hospital, 747 Poonamallee High Road, Kilpauk, Chennai 600010

References

  1. O'Malley BW Jr, et al. "Transoral robotic surgery (TORS): a new approach to upper airway lesions." The Laryngoscope, 2006.
  2. Weinstein GS, et al. "Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins." The Laryngoscope, 2007.
  3. National Comprehensive Cancer Network (NCCN). "Head and Neck Cancers." NCCN Guidelines, 2024.
  4. American Cancer Society. "Throat Cancer Treatment Options." 2024.
  5. Genden EM, et al. "Transoral robotic surgery for head and neck cancer: a prospective review." Head & Neck, 2011.
  6. Cleveland Clinic. "Transoral Robotic Surgery (TORS)." 2024.

Share this article

Dr. Vidhyadharan Sivakumar

Written by

Dr. Vidhyadharan Sivakumar

MS, DNB, MRCS (Ed), MCh (Surgical Oncology)

Clinical Director & Senior Consultant at THANC Hospital, Chennai. India's pioneer in Transoral Robotic Surgery (TORS) with 15+ years of experience in complex head & neck cancer treatment.

Head Neck Skullbase & Throat CancerRobotic Surgery (TORS)Thyroid & ParathyroidVoice RestorationSleep Apnea SurgeryHead & Neck Reconstruction
THANC Hospital, Chennai

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Every patient's condition is unique. Please consult Dr. Vidhyadharan or a qualified healthcare provider for proper diagnosis and personalized treatment recommendations.

Frequently Asked Questions

What is TORS robotic surgery?

TORS (Transoral Robotic Surgery) is a minimally invasive surgical technique using the da Vinci robot to remove throat tumors through the mouth. It offers enhanced precision, 3D visualization, and faster recovery compared to traditional open surgery.

What cancers can TORS treat?

TORS effectively treats tonsil cancer, base of tongue cancer, oropharyngeal cancer, early laryngeal cancer, and HPV-positive throat cancers. The tumor must be accessible through the mouth for TORS to be suitable.

What are the benefits of TORS over traditional surgery?

TORS offers no external scars, shorter hospital stay (2-4 days vs 7-14), faster recovery (3-4 weeks vs 6-12 weeks), better speech and swallowing preservation, reduced pain, and potentially avoiding radiation therapy in early-stage cancers.

How long is recovery after TORS surgery?

Most TORS patients return home in 2-4 days and resume normal activities in 3-4 weeks. Some temporary throat soreness and swallowing difficulty is normal. Speech therapy helps optimize recovery.

What is the cost of TORS surgery in Chennai?

TORS surgery in Chennai costs approximately INR 4-8 lakhs depending on tumor complexity, hospital stay, and individual needs. THANC Hospital provides detailed estimates after consultation.

Who is the best TORS surgeon in Chennai?

Dr. Vidhyadharan Sivakumar at THANC Hospital is a leading TORS expert in Chennai. He performed India's first TORS-assisted total laryngectomy (2022) and is fellowship-trained in robotic surgery with extensive international training.

Is TORS covered by insurance in India?

Many insurance policies cover TORS for cancer treatment. Coverage varies by provider and policy. THANC Hospital's team assists with insurance pre-authorization and documentation.

How does TORS compare to radiation therapy?

For early-stage throat cancer, TORS offers single surgery vs 6-7 weeks of daily radiation. TORS avoids radiation side effects like permanent dry mouth, taste changes, and dental problems. Radiation remains available as backup if needed after TORS.

What are the risks of TORS surgery?

Common temporary effects include throat pain and difficulty swallowing. Uncommon risks (1-2%) include bleeding and infection. Rare complications include prolonged swallowing difficulty or voice changes. Overall complication rates are lower than traditional surgery.

Am I a candidate for TORS?

TORS is suitable for early to moderate stage (I-III) throat tumors that are accessible through the mouth. You need adequate mouth opening and fitness for general anesthesia. A consultation with Dr. Vidhyadharan will determine your candidacy.

Where is TORS available in Chennai?

TORS is available at THANC Hospital (The Head and Neck Centre & Hospital), 747 Poonamallee High Road, Kilpauk, Chennai 600010. Call +91 44 4074 2000 for appointments.

What is the success rate of TORS?

TORS achieves 85-95% tumor control for early-stage throat cancers. Over 90% of patients maintain good speech and return to near-normal swallowing. Long-term quality of life outcomes are superior to traditional approaches.